Highlights and Quick Summary
- Free Cash Flow per Share for the quarter ending September 30, 2022 was -0.92 (a 292.31% increase compared to previous quarter)
- Year-over-year quarterly Free Cash Flow per Share decreased by -2.16%
- Annual Free Cash Flow per Share for 2021 was -3.78 (a 9.63% increase from previous year)
- Annual Free Cash Flow per Share for 2020 was -3.45 (a 41.57% increase from previous year)
- Annual Free Cash Flow per Share for 2019 was -2.44 (a 8.47% increase from previous year)
- Twelve month Free Cash Flow per Share ending September 30, 2022 was -3.4 (a 8.75% increase compared to previous quarter)
- Twelve month trailing Free Cash Flow per Share decreased by -3.33% year-over-year
Trailing Free Cash Flow per Share for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -3.4 | -3.13 | -3.56 | -3.52 |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow per Share of BridgeBio Pharma, Inc.
Most recent Free Cash Flow per Shareof BBIO including historical data for past 10 years.Interactive Chart of Free Cash Flow per Share of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Free Cash Flow per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -0.92 | -0.23 | -1.11 | – |
| 2021 | -0.94 | -1.11 | -0.64 | -1.1 | -3.78 |
| 2020 | -0.84 | -1.12 | -0.75 | -0.75 | -3.45 |
| 2019 | -0.74 | -0.43 | -0.74 | -0.65 | -2.44 |
| 2018 | – | – | 0.0 | -1.5 | -2.25 |
| 2017 | 0.0 | – | – | – | -0.35 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology